The consulting giant narrowed its full-year revenue growth forecast as US federal business slowdowns weigh on results
Accenture, the world’s largest publicly traded consulting firm, saw its stock crater after the company trimmed its fiscal year 2026 revenue growth outlook. The culprit: slower procurement cycles and a wave of contract reviews tied to its US federal government business.
The company reported fiscal Q3 2026 revenue of $18.7 billion, which grew 6% year-over-year in USD terms and 3% in local currency. Analysts were expecting roughly $18.78 billion.
What happened to the guidance
Accenture narrowed its full-year fiscal 2026 revenue growth guidance in local currency to a range of 3% to 4%. The prior forecast was 3% to 5%.
The primary drag comes from Accenture’s US federal business, which the company expects to shave 1% to 1.5% off its overall growth rate. Slower procurement cycles and ongoing reviews of consulting contracts with the federal government are creating the headwind.
The earnings call was scheduled for 8:00 a.m. EDT on June 18, 2026, and by the time premarket trading opened, shares had already dropped approximately 9.6%. The stock ultimately plunged 19% as investors digested the implications.
The contagion effect
Accenture’s pain didn’t stay contained. Capgemini, the French IT services and consulting rival, saw its own shares tumble more than 8% in the wake of Accenture’s report.
Why this matters beyond traditional markets
The company notably made no references to cryptocurrency or digital asset initiatives in its earnings context. During the 2021-2022 cycle, major consulting firms were loudly trumpeting their Web3 and blockchain practices. The silence now suggests these offerings remain peripheral to core business concerns, or at minimum, aren’t material enough to warrant mention during an earnings call where management needed to explain a guidance cut.
Traders should watch upcoming earnings from other major consulting and IT services firms to determine whether this is a sector-wide repricing or whether Accenture’s federal exposure makes it uniquely vulnerable.
